Weill Cornell Receives NIH Grant to Develop Portable PET Scanner for Alzheimer Disease

Siemens Healthineers to Buy Novartis Molecular Imaging Unit for $224 Million

Molecular Imaging Technique Accurately Detects Neuroblastoma in Children With Short Scan Time, No Anesthesia

Molecular Imaging Tool Objectively Measures Anosmia

UC-Davis-Built PET Scanner Can Visualize Blood Supply in Lung Cancer

SNMMI Announces 2024 Fellows and Awards, Votes in New Leadership

PSMA PET/CT SUVmax Helps Predict Likelihood of Clinically Significant Prostate Cancer in Biopsy

Not All Prostate-Specific Membrane Antigen Imaging Agents Are Created Equal: Diagnostic Accuracy of Ga-68 PSMA-11 PET/CT for Initial and Recurrent Prostate Cancer

By Purysko AS, Abreu AL, Lin DW, Punnen S

Somatostatin Receptor PET Imaging of Physiologic and Benign Processes: Implications for Image Interpretation, Avoiding Pitfalls, and Clinical Applications

By Raynor WY, Kempf JS

Multicystic Dysplastic Kidney

By Hamman S, Loeb SR, Jorgensen SA, Towbin AJ, Towbin RB

A Conversation with SNMMI Past President, Dr. Richard Wahl

Researchers Improve Scanning Capability of Magnetic Particle Imaging System

PSMA Radioligand Therapy | Advances in Prostate Cancer Treatments | Part 4

PSMA Radioligand Therapy | Advances in Prostate Cancer Treatments | Part 3

PSMA Radioligand Therapy | Advances in Prostate Cancer Treatments | Part 2

PSMA Radioligand Therapy | Advances in Prostate Cancer Treatments | Part 1

ACNM Announces New President

ImagingAb to Launch ImmunoPET Technology in China, Announces Phase IIb Study

PET Scans Guide Treatment for Orthopedic Implant Bacterial Infections

First Major CT Imaging Advancement in Nearly a Decade Cleared by US FDA

PSMA PET/CT | Clinical Utility in Prostate Imaging

SNMMI Selects New Officers During Virtual Annual Meeting

SNMMI ’21: New PET Tracer Detects Hallmark of Alzheimer’s Disease Years Before Symptoms Emerge

SNMMI '21: Super-resolution PET with Motion Tracking Enables More Detailed Brain Imaging

SubtlePET 2.0 Gets CE Mark

FDA Clears AI-based Reconstruction Technology for Cartesion Prime PET/CT System

F-18 PET Imaging Better Informs Treatment Planning in Recurrent Prostate Cancer

Study Finds Abnormal Radiotracer Uptake on PET After COVID Vaccination

ISMRM Announces New President, Awards Gold Medals at Annual Meeting

Clinicians Gain Early Insight using Immuno-PET to Evaluate Tumor Response from Targeted Therapy

A Primary Hepatic Neuroendocrine Carcinoma

By Ban DM, Koscheski P

Localized Prostate Cancer Recurrence

By Karnes RJ, Ahmed ME

FDA Clears Siemens Healthineers Biograph Vision Quadra PET/CT Scanner

Study Finds Biomarkers in PET/CT and Blood are Indicators of Active Sarcoidosis

Model helps predict which patients will benefit most from PSMA PET scan

Theragnostics Announces Research Collaboration with Essen University Hospital to Study THG-008 for Oncology PET Imaging

Delivering on the Promise: Telix Anticipates Demand for 68GA PSMA-11

Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

Going Beyond Traditional Diagnostics and Therapies, Delivering Precise Cancer Treatments

The Promise of Nuclear Medicine: Developing Cancer Detection and Treatment with Molecularly Targeted Radiation (MTR)